Involvement of the Nrf2/HO‐1/CO axis and therapeutic intervention with the CO‐releasing molecule CORM‐A1, in a murine model of autoimmune hepatitis
Katia Mangano(University of Catania), Paolo Fagone(University of Catania), Antonio Pesce(University of Catania), Santa Mammana(University of Catania), Maria Sofia Basile(University of Catania), Atanas G. Atanasov(University of Vienna), Rosario Caltabiano(University of Catania), Stefano Puleo(Istituto di Studi sul Mediterraneo (CNR - ISMed)), Gaetano Magro(University of Catania), Ferdinando Nicoletti(University of Catania), Eugenio Cavalli(Centro Neurolesi Bonino Pulejo)
Cited by 55
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495